Skip to content

Clinical trials

Phase 2 Carcinoma, Non-Small-Cell Lung trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2 Country / region: India Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20071
20086
20103
20111
20151
20181
20192
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting2
Terminated2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peregrine Pharmaceuticals3
AstraZeneca2
Eli Lilly and Company2
Tata Memorial Hospital2
Bayer1
BioMarck Pharmaceuticals, Ltd.1
Bristol-Myers Squibb1
Cadila Pharnmaceuticals1
CytRx1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung20
Lung Neoplasms6
Carcinoma2
Neoplasm Metastasis2
Small Cell Lung Carcinoma2
Biliary Tract Neoplasms1
Breast Neoplasms1
Colorectal Neoplasms1
Melanoma1
Neoplasms1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.